Navigating the Pathology Minefield: Harnessing the Value of Historical Control Data in Rodent Carcinogenicity Studies

A reliable and robust historical control database for tumors in control rodents, used in lifetime carcinogenicity bioassays, is an essential tool for laboratories conducting such studies. It provides a quality check for the concurrent control for a given study and, in the event that the concurrent control is deficient in some respect, it permits an objective comparison of the control incidences to those present in the respective treated groups. This review details the conditions where a HCD may help, the factors that need to be taken into account when constructing a quality HCD, and the numerical alternatives that should be considered when using the data. It is emphasized throughout the review that HCD should not be used in isolation to dismiss an apparent treatment-related increased tumor incidence and should never supersede a detailed "weight of evidence" evaluation in coming to any conclusion as to the result of a carcinogenicity bioassay. Finally the review briefly discusses the potential for the HCD to replace the use of a concurrent control group in such studies.

Authors

Publication Details

Journal
Toxicologic Pathology
Published
2026-02-22
DOI
https://doi.org/10.1177/01926233261420213
Primary Topic
Carcinogens and Genotoxicity Assessment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Navigating the Pathology Minefield: Harnessing the Value of Historical Control Data in Rodent Carcinogenicity Studies

John R. Foster
Toxicologic Pathology
Carcinogens and Genotoxicity Assessment
article

Navigating the Pathology Minefield: Harnessing the Value of Historical Control Data in Rodent Carcinogenicity Studies

John R. Foster
article en

Abstract

A reliable and robust historical control database for tumors in control rodents, used in lifetime carcinogenicity bioassays, is an essential tool for laboratories conducting such studies. It provides a quality check for the concurrent control for a given study and, in the event that the concurrent control is deficient in some respect, it permits an objective comparison of the control incidences to those present in the respective treated groups. This review details the conditions where a HCD may help, the factors that need to be taken into account when constructing a quality HCD, and the numerical alternatives that should be considered when using the data. It is emphasized throughout the review that HCD should not be used in isolation to dismiss an apparent treatment-related increased tumor incidence and should never supersede a detailed "weight of evidence" evaluation in coming to any conclusion as to the result of a carcinogenicity bioassay. Finally the review briefly discusses the potential for the HCD to replace the use of a concurrent control group in such studies.

Toxicologic Pathology
Good health and well-being
Openalex Percentile: Top 45%
Carcinogens and Genotoxicity Assessment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Navigating the Pathology Minefield: Harnessing the Value of Historical Control Data in Rodent Carcinogenicity Studies — John R. Foster · Toxicologic Pathology (2026) | TGRS Research Map | TGRS